Home/Filings/4/0001209191-19-031524
4//SEC Filing

Bright Rex 4

Accession 0001209191-19-031524

CIK 0001606645other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 6:27 PM ET

Size

5.5 KB

Accession

0001209191-19-031524

Insider Transaction Report

Form 4
Period: 2019-05-16
Bright Rex
Director
Transactions
  • Award

    Options

    2019-05-16+49,41249,412 total
    Exercise: $2.66Exp: 2029-05-16Ordinary Shares (49,412 underlying)
Footnotes (2)
  • [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
  • [F2]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020.

Issuer

Foamix Pharmaceuticals Ltd.

CIK 0001606645

Entity typeother

Related Parties

1
  • filerCIK 0001327501

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:27 PM ET
Size
5.5 KB